NanoVibronix Plunges 8.33% Amid Volatility

On June 12, 2025, NanoVibronix experienced a significant drop of 8.33% in pre-market trading, reflecting a notable decline in investor sentiment.

NanoVibronix Inc.'s stock has seen substantial volatility in recent weeks, with a 94.22% increase driven by positive market sentiment following recent FDA designations. This surge in stock price was further highlighted by a nearly 90% increase in early trading on June 11, 2025, indicating strong investor interest in the company's medical technology solutions.

However, the company has also faced challenges, including a 10.83% decrease during the after-hours session on the same day, which may have contributed to the pre-market drop. Additionally, NanoVibronix clarified that it is not proceeding with a $26 million stock offering, addressing false claims and potentially stabilizing investor confidence.

Despite the recent volatility, NanoVibronix continues to advance its non-invasive and minimally invasive medical solutions, positioning itself as a key player in the surgical appliances and supplies industry. The company's stock holds sell signals from both short and long-term moving averages, suggesting a more negative forecast for the stock in the near term.